The Drug Company That Prospered Without Creating Any Drugs
By Arthur Allen
Horizon Therapeutics, which Amgen is acquiring for about $28 billion, grew large by snapping up cheap drugs from other companies, marketing them to perfection, and jacking up prices.
La empresa farmacéutica que prosperó sin crear ni un solo medicamento
By Arthur Allen
Aunque Horizon afirma que ahora tiene 20 fármacos en desarrollo, en sus 15 años de existencia aún no ha obtenido la licencia de un producto de su creación.
Daily Edition for Wednesday, April 12, 2023
Malnutrition, maternal health, nursing incentives, covid, abortion pills, the opioids crisis, mental health, and more are in the news.
Feds Launch Criminal Investigation Into ‘AGGA’ Dental Device and Its Inventor
By Brett Kelman and Anna Werner, CBS News
KFF Health News and CBS News recently reported that multiple lawsuits allege the device has led to grievous injuries to patients’ mouths, resulting in loss of teeth.
As Montana’s Mental Health Crisis Care Crumbles, Politicians Promise Aid
By Katheryn Houghton
One of Montana’s largest mental health providers has ratcheted back services amid financial troubles, leaving a vacuum. State policymakers have promised more money to aid behavioral health care, but lasting change could be years out.
Aumenta el número de californianos mayores que muere por desnutrición
By Phillip Reese
Las muertes atribuidas a la desnutrición aumentaron más del doble, de unas 650 en 2018 a aproximadamente 1,400 en 2022, según datos preliminares de certificados de defunción del Departamento de Salud Pública estatal.
Daily Edition for Tuesday, April 11, 2023
Abortion pill stockpiling, antibiotic-resistant bacteria, vaccine development, covid variants, health personnel, and more are in the news.
Most Americans Say They or a Family Member Has Experienced Gun Violence
By Liz Szabo
More than 1 in 5 Americans report having been threatened with a firearm, and almost as many say they worry about gun violence every day or almost every day, a new KFF poll shows.
Doctors’ Lesson for Drug Industry: Abortion Wars Are Dangerous to Ignore
By Julie Rovner
The American Medical Association ducked the abortion issue for years and now sees its members’ professional opinions second-guessed by lawmakers and judges. PhRMA is following the same playbook.
